McDonald, Scott A <br/><br/>
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?  [electronic resource] 

 -  Journal of hepatology  Feb 2015 
 - 262-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2014.08.046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Polyethylene Glycols--therapeutic use<br/>RNA, Viral--genetics<br/>Recombinant Proteins--therapeutic use<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Treatment Outcome<br/>Viral Load